Home
/
GoodRx Holdings, Inc.
/
Financials
/
Quarterly
GoodRx Holdings, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that GoodRx Holdings, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$196.03M
Nov 4, 2025
Q2
2025
Jun 30, 2025
$203.07M
Aug 6, 2025
Q1
2025
Mar 31, 2025
$202.97M
May 7, 2025
Q3
2025
Sep 30, 2024
$195.25M
Nov 4, 2025
Q2
2025
Jun 30, 2024
$200.61M
Aug 6, 2025
Q1
2025
Mar 31, 2024
$197.88M
May 7, 2025
Q3
2024
Sep 30, 2023
$179.96M
Nov 7, 2024
Q2
2024
Jun 30, 2023
$189.68M
Aug 8, 2024
Q1
2024
Mar 31, 2023
$183.99M
May 9, 2024
Q3
2023
Sep 30, 2022
$187.32M
Nov 9, 2023
Q2
2023
Jun 30, 2022
$191.80M
Aug 9, 2023
Q1
2023
Mar 31, 2022
$203.33M
May 10, 2023
Q3
2022
Sep 30, 2021
$195.10M
Nov 9, 2022
Q2
2022
Jun 30, 2021
$176.64M
Aug 9, 2022
Q1
2022
Mar 31, 2021
$160.43M
May 10, 2022
Q3
2021
Sep 30, 2020
$140.45M
Nov 12, 2021
Q2
2021
Jun 30, 2020
$123.30M
Aug 12, 2021
Q1
2021
Mar 31, 2020
$133.41M
May 14, 2021
Q3
2020
Sep 30, 2019
$101.75M
Nov 12, 2020
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$1.12M
Nov 4, 2025
Q3
2025
Jun 30, 2025
$12.84M
Nov 4, 2025
Q2
2025
Jun 30, 2025
$12.84M
Aug 6, 2025
Q3
2025
Mar 31, 2025
$11.05M
Nov 4, 2025
Q1
2025
Mar 31, 2025
$11.05M
May 7, 2025
Q2
2025
Mar 31, 2025
$11.05M
Aug 6, 2025
Q3
2025
Sep 30, 2024
$3.97M
Nov 4, 2025
Q2
2025
Jun 30, 2024
$6.69M
Aug 6, 2025
Q3
2025
Jun 30, 2024
$6.69M
Nov 4, 2025
Q3
2025
Mar 31, 2024
($1.01M)
Nov 4, 2025
Q2
2025
Mar 31, 2024
($1.01M)
Aug 6, 2025
Q1
2025
Mar 31, 2024
($1.01M)
May 7, 2025
Q3
2024
Sep 30, 2023
($38.50M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
$58.79M
Aug 8, 2024
Q3
2024
Jun 30, 2023
$58.79M
Nov 7, 2024
Q1
2024
Mar 31, 2023
($3.29M)
May 9, 2024
Q3
2024
Mar 31, 2023
($3.29M)
Nov 7, 2024
Q2
2024
Mar 31, 2023
($3.29M)
Aug 8, 2024
Q3
2023
Sep 30, 2022
($41.73M)
Nov 9, 2023
Q3
2023
Jun 30, 2022
($1.42M)
Nov 9, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$14.62M
Nov 4, 2025
Q2
2025
Jun 30, 2025
$26.81M
Aug 6, 2025
Q1
2025
Mar 31, 2025
$23.38M
May 7, 2025
Q3
2025
Sep 30, 2024
$20.41M
Nov 4, 2025
Q2
2025
Jun 30, 2024
$19.88M
Aug 6, 2025
Q1
2025
Mar 31, 2024
$7.38M
May 7, 2025
Q3
2024
Sep 30, 2023
($38.33M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
$18.31M
Aug 8, 2024
Q1
2024
Mar 31, 2023
$11.30M
May 9, 2024
Q3
2023
Sep 30, 2022
($15.71M)
Nov 9, 2023
Q2
2023
Jun 30, 2022
($4.05M)
Aug 9, 2023
Q1
2023
Mar 31, 2022
$19.76M
May 10, 2023
Q3
2022
Sep 30, 2021
$7.00M
Nov 9, 2022
Q2
2022
Jun 30, 2021
($351.0K)
Aug 9, 2022
Q1
2022
Mar 31, 2021
($5.00M)
May 10, 2022
Q3
2021
Sep 30, 2020
($61.69M)
Nov 12, 2021
Q2
2021
Jun 30, 2020
$41.74M
Aug 12, 2021
Q1
2021
Mar 31, 2020
$43.67M
May 14, 2021
Q3
2020
Sep 30, 2019
$37.84M
Nov 12, 2020